Intermediate-risk Non–muscle-invasive Bladder Cancer: Recommendations for Definitions, Risk Stratification, Management Strategies, and Clinical Trial Design from the International Bladder Cancer Group
Roger Li, Patrick J. Hensley, Marko Babjuk, Laura Bukavina, Sarah P. Psutka, Seth P. Lerner, Michael A. O’Donnell, Yair Lotan, Kelly K. Bree, Joan Palou Redorta, David J. McConkey, Byron Lee, Paramananthan Mariappan, Laura S. Mertens, Mark S. Soloway, Robert S. Svatek, Wei Shen Tan, Stephen B. Williams, Shilpa Gupta, Roger Buckley, Ashish M. Kamat
Topics & Concepts
MedicineClinical trialBladder cancerResearch designClinical study designInternal medicineOncologyMEDLINEIntensive care medicineClinical researchStandard of careClinical PracticeRandomized controlled trialPatient careRisk assessmentUrinary bladderDisease managementCancerBladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology StudiesUrinary Bladder and Prostate Research